Literature DB >> 20407010

LATS1 phosphorylates forkhead L2 and regulates its transcriptional activity.

Margareta D Pisarska1, Fang-Ting Kuo, Ikuko K Bentsi-Barnes, Salma Khan, Gillian M Barlow.   

Abstract

Forkhead L2 (FOXL2) is expressed in the ovary and acts as a transcriptional repressor of the steroidogenic acute regulatory (StAR) gene, a marker of granulosa cell differentiation. Human FOXL2 mutations that produce truncated proteins lacking the COOH terminus result in blepharophimosis/ptosis/epicanthus inversus (BPES) syndrome type I, which is associated with premature ovarian failure (POF). In this study, we investigated whether FOXL2's activity as a transcriptional repressor is regulated by phosphorylation. We found that FOXL2 is phosphorylated at a serine residue and, using yeast two-hybrid screening, identified LATS1 as a potential FOXL2-interacting protein. LATS1 is a serine/threonine kinase whose deletion in mice results in an ovarian phenotype similar to POF. Using coimmunoprecipitation and kinase assays, we confirmed that LATS1 binds to FOXL2 and demonstrated that LATS1 phosphorylates FOXL2 at a serine residue. Moreover, we found that FOXL2 and LATS1 are coexpressed in developing mouse gonads and in granulosa cells of small and medium follicles in the mouse ovary. Last, we demonstrated that coexpression with LATS1 enhances FOXL2's activity as a repressor of the StAR promoter, and this results from the kinase activity of LATS1. These results provide novel evidence that FOXL2 is phosphorylated by LATS1 and that this phosphorylation enhances the transcriptional repression of the StAR gene, a marker of granulosa cell differentiation. These data support our hypothesis that phosphorylation of FOXL2 may be a control mechanism regulating the rate of granulosa cell differentiation and hence, follicle maturation, and its dysregulation may contribute to accelerated follicular development and POF in BPES type I.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20407010      PMCID: PMC2904049          DOI: 10.1152/ajpendo.00534.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  60 in total

Review 1.  The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals.

Authors:  Qi Zeng; Wanjin Hong
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

Review 2.  Structure/function relationships underlying regulation of FOXO transcription factors.

Authors:  T Obsil; V Obsilova
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

Review 3.  Five years on the wings of fork head.

Authors:  E Kaufmann; W Knöchel
Journal:  Mech Dev       Date:  1996-06       Impact factor: 1.882

4.  Transcriptional activation. Something new to hang your HAT on.

Authors:  M Montminy
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

Review 5.  Immune modulators in the context of the ovulatory process: a role for interleukin-1.

Authors:  E Y Adashi
Journal:  Am J Reprod Immunol       Date:  1996-03       Impact factor: 3.886

6.  Localization of the steroidogenic acute regulatory protein in human tissues.

Authors:  S E Pollack; E E Furth; C B Kallen; F Arakane; M Kiriakidou; K F Kozarsky; J F Strauss
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

7.  Tumor suppressor LATS1 is a negative regulator of oncogene YAP.

Authors:  Yawei Hao; Alex Chun; Kevin Cheung; Babak Rashidi; Xiaolong Yang
Journal:  J Biol Chem       Date:  2007-12-24       Impact factor: 5.157

8.  The post-translational modification profile of the forkhead transcription factor FOXL2 suggests the existence of parallel processive/concerted modification pathways.

Authors:  Bérénice A Benayoun; Jana Auer; Sandrine Caburet; Reiner A Veitia
Journal:  Proteomics       Date:  2008-08       Impact factor: 3.984

9.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

Authors:  Bin Zhao; Xiaomu Wei; Weiquan Li; Ryan S Udan; Qian Yang; Joungmok Kim; Joe Xie; Tsuneo Ikenoue; Jindan Yu; Li Li; Pan Zheng; Keqiang Ye; Arul Chinnaiyan; Georg Halder; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

10.  Sumoylation of forkhead L2 by Ubc9 is required for its activity as a transcriptional repressor of the Steroidogenic Acute Regulatory gene.

Authors:  Fang-Ting Kuo; Ikuko K Bentsi-Barnes; Gillian M Barlow; Jeehyeon Bae; Margareta D Pisarska
Journal:  Cell Signal       Date:  2009-09-08       Impact factor: 4.315

View more
  21 in total

1.  FOXO1/3 and PTEN Depletion in Granulosa Cells Promotes Ovarian Granulosa Cell Tumor Development.

Authors:  Zhilin Liu; Yi A Ren; Stephanie A Pangas; Jaye Adams; Wei Zhou; Diego H Castrillon; Dagmar Wilhelm; JoAnne S Richards
Journal:  Mol Endocrinol       Date:  2015-06-10

2.  Subcellular localization and characterization of estrogenic pathway regulators and mediators in Atlantic salmon spermatozoal cells.

Authors:  Kristian R von Schalburg; Brent E Gowen; Jong S Leong; Eric B Rondeau; William S Davidson; Ben F Koop
Journal:  Histochem Cell Biol       Date:  2017-10-05       Impact factor: 4.304

3.  Mutant Forkhead L2 (FOXL2) proteins associated with premature ovarian failure (POF) dimerize with wild-type FOXL2, leading to altered regulation of genes associated with granulosa cell differentiation.

Authors:  Fang-Ting Kuo; Ikuko K Bentsi-Barnes; Gillian M Barlow; Margareta D Pisarska
Journal:  Endocrinology       Date:  2011-08-23       Impact factor: 4.736

Review 4.  Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology.

Authors:  Margareta D Pisarska; Gillian Barlow; Fang-Ting Kuo
Journal:  Endocrinology       Date:  2011-01-19       Impact factor: 4.736

Review 5.  Fox tales: regulation of gonadotropin gene expression by forkhead transcription factors.

Authors:  Varykina G Thackray
Journal:  Mol Cell Endocrinol       Date:  2013-10-04       Impact factor: 4.102

6.  Roles of binding elements, FOXL2 domains, and interactions with cJUN and SMADs in regulation of FSHβ.

Authors:  Lacey L Roybal; Arpi Hambarchyan; Jason D Meadows; Nermeen H Barakat; Patricia A Pepa; Kellie M Breen; Pamela L Mellon; Djurdjica Coss
Journal:  Mol Endocrinol       Date:  2014-08-08

Review 7.  Intraovarian control of early folliculogenesis.

Authors:  Aaron J W Hsueh; Kazuhiro Kawamura; Yuan Cheng; Bart C J M Fauser
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

8.  Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment.

Authors:  Kazuhiro Kawamura; Yuan Cheng; Nao Suzuki; Masashi Deguchi; Yorino Sato; Seido Takae; Chi-hong Ho; Nanami Kawamura; Midori Tamura; Shu Hashimoto; Yodo Sugishita; Yoshiharu Morimoto; Yoshihiko Hosoi; Nobuhito Yoshioka; Bunpei Ishizuka; Aaron J Hsueh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

9.  Novel action of FOXL2 as mediator of Col1a2 gene autoregulation.

Authors:  Mara Marongiu; Manila Deiana; Loredana Marcia; Andrea Sbardellati; Isadora Asunis; Alessandra Meloni; Andrea Angius; Roberto Cusano; Angela Loi; Francesca Crobu; Giorgio Fotia; Francesco Cucca; David Schlessinger; Laura Crisponi
Journal:  Dev Biol       Date:  2016-05-19       Impact factor: 3.582

10.  Improved preservation of ovarian tissue morphology that is compatible with antigen detection using a fixative mixture of formalin and acetic acid.

Authors:  B V Adeniran; B D Bjarkadottir; R Appeltant; S Lane; S A Williams
Journal:  Hum Reprod       Date:  2021-06-18       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.